The methylases METTL3 and RBM15B are differentially expressed in the hippocampus of patients with AD, while in the insoluble fraction, the expression level of METTL3 is positively correlated with aberrantly phosphorylated tau (75). This evidence concerns the gene MAPT and Alzheimer disease.